{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-040845","form_type":"8-K","ticker":"SONM","cik":"0001178697","company_name":"DNA X, Inc.","filed_at":"2026-08-31T20:59:24+00:00","discovered_at":"2026-08-31T21:02:08.550080+00:00","generated_at":"2026-08-31T21:02:33.878809+00:00","sec_items":["8.01"],"event_type":"regulatory","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"DNA X regains Nasdaq equity compliance; monitor period through Aug 2027","bullets":["Received Nasdaq Panel letter on Aug 28, 2026 confirming compliance with Listing Rule 5550(b)(1) ($2.5M stockholders' equity requirement).","Securities remain subject to delisting if compliance not maintained until Nov 18, 2026.","Mandatory panel monitor until Aug 28, 2027; new non-compliance triggers delisting determination without cure period.","Company may request hearing with Panel if delisting is proposed."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-040845","json":"https://secwatch.observer/filing/0001493152-26-040845.json","markdown":"https://secwatch.observer/filing/0001493152-26-040845.md","text":"https://secwatch.observer/filing/0001493152-26-040845.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1178697/000149315226040845/0001493152-26-040845-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1178697/000149315226040845/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-31T21:02:33.878809+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}